8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Pfizer ($PFE) issued a press release on Feb 3, 2026 announcing fourth‑quarter 2025 financial results; the…
Filed with the SEC on · Summarized by InvestorsBot
Pfizer ($PFE) issued a press release on Feb 3, 2026 announcing fourth‑quarter 2025 financial results; the press release is furnished as Exhibit 99 to the 8‑K. 📢 #Pfizer #earnings
The Item 2.02 info (including Exhibit 99) is furnished—not “filed”—under the Exchange Act, so it’s not subject to Section 18 liabilities or automatically incorporated by reference into future filings unless expressly stated. ⚖️ $PFE #SEC #disclosure
Investors: this 8‑K text contains no financial figures—review Exhibit 99/press release (furnished Feb 3, 2026) for full Q4 2025 results and details. 🔎 $PFE #Q4 #investors